Dear Editor-in-Chief, Developmental venous anomalies (DVAs) are generally considered as normal anatomic variant and may occur across the entire brain. Occasionally, DVAs are associated with cavernomas, and those cavernomas may sometimes induce clinical symptoms including seizure or intracranial hemorrhage.
We present four patients undergoing imaging due to complaints of progressive memory loss with perihippocampal DVAs (Figs. 1, 2, 3 , and 4). Evidently, this could be a simple coincidence, and the prevalence of peri-hippocampal DVAs in persons without memory loss is unknown.
However, we want to formulate the hypothesis that peri-hippocampal DVAs might contribute to memory loss. This might be related to associated lesions, such as micro-cavernomas, which are not always visible on routine clinical MR imaging yet might impact the normal functioning of the hippocampus. Or, this could either be related to local alterations of blood flow [1] , which might lead to a misbalance of arterial inflow and venous outflow and consequently could accelerate hippocampal neuronal loss. Alternatively, DVAs might lead to subclinical (local) epilepsy, which might interfere with the normal hippocampal function [2] .
It is evident that based on the available evidence, we cannot confirm nor reject the hypothesis that perihippocampal DVAs might contribute to memory loss. The aim of this letter is to draw the attention of our colleagues to this hypothesis and imaging finding. This is of particular interest because most CT or MR protocols for workup of cognitive decline are performed without contrast administration. As it is very difficult or even impossible to detect notably smaller DVAs without contrast administration, the prevalence of perihippocampal DVAs in patients with memory loss might actually be underestimated, notably if not specifically scrutinizing the scans for this sign.
We hope that based on the presented cases, we can raise in our community the awareness of perihippocampal DVAs and memory loss and subsequently create the evidence needed to allow us to confirm or reject the hypothesis of a potential interaction of perihippocampal DVA and memory loss. 
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